The US authorities announced the discontinuation of experiments with a vaccine called “HVTN 702” for the treatment of HIV “AIDS”, which began work in 2016 and enlisted 5,400 people who do not have HIV in 14 regions of South Africa, men and women. After the vaccine showed its ineffectiveness in combating the epidemic, according to Al Arabiya Net “.
For his part, Anthony Fuchi, director of the National Institute of Allergy and Infectious Diseases, who supervised the trial of an anti-HIV vaccine in South Africa, said: “We had hoped that this vaccine would succeed … Unfortunately it failed,” expressing disappointment with this failure, stressing that It is “necessary to find an HIV vaccine to end the global epidemic“.
The vaccine trial, which was called “HTTN 702,” began in 2016, and included the only vaccine that showed it provides some protection against the virus that causes AIDS in a previous trial in Thailand in 2009..
About 5400 non-HIV volunteers participated in the experiment in 14 regions of South Africa, men and women between the ages of 18 and 35 years, randomly chosen to receive the vaccine or placebo. In order to ensure the safety of the participants, they were also provided with proven preventative drugs to prevent HIV infection.
It was found that 129 HIV infections occurred among the vaccine recipients, and 123 HIV infections occurred among the placebo recipients and thus the trial was stopped..
“It is a major setback in this area, but we need to continue to search for a preventive vaccine,” said Linda Gil Baker, supervisor of the experiment and former president of the International AIDS Association.“.
Other experiments to find a vaccine are under way, including one in sub-Saharan Africa and South Africa, and another that is being carried out in several regions of North America, South America, and Europe..
– .
